|

Clopidogrel Clinical Trials

7 actively recruiting trials across 1 location

Also known as: Clopidogrel Hydrogen Sulphate Tablets, Platless Tab., Plavix

Pipeline

Phase 2: 1Phase 3: 1Phase 4: 5

Top Sponsors

  • University of Florida2
  • St. Antonius Hospital1
  • Seoul National University Bundang Hospital1
  • Peking Union Medical College Hospital1
  • Medical University of Gdansk1

Indications

  • Heart Disease6
  • Acute Coronary Syndrome2
  • Coronary Artery Disease2
  • Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)1
  • CYP2C19 Polymorphism1

Other5 trials

Anti-platelet Effect of Berberine in Patients After Percutaneous Coronary Intervention
Phase 4
Clopidogrel Versus Cilostazol on Vessels
Phase 4
Dual Antithrombotic Therapy With Dabigatran and Ticagrelor in Patients With ACS and Non-valvular AF Undergoing PCI
Phase 4
Efficacy and Safety Study of Vicagrel in Patients With Acute Coronary Syndrome (ACS) Undergoing Percutaneous Coronary Intervention (PCI)
Phase 3
POPular GUILTY PILOT: Genotype-guided Clopidogrel Monotherapy
Phase 2

Jacksonville, Florida2 trials

Dual Antiplatelet Therapy Escalation From Standard-dose Clopidogrel to Low-Dose Prasugrel in Patients With High Bleeding and Ischemic Risk Undergoing PCI: A Prospective, Randomized Pharmacodynamic Study (TAILOR-BLEED-2)

University of Florida Health

Phase 4
Effects of Low-dose Ticagrelor vs. Clopidogrel in Stable Patients Undergoing Elective Percutaneous Coronary Intervention

University of Florida Jacksonville

Phase 4

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.